BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11988353)

  • 1. Hot spot pollutants: pharmaceuticals in the environment.
    Dietrich DR; Webb SF; Petry T
    Toxicol Lett; 2002 May; 131(1-2):1-3. PubMed ID: 11988353
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeating history: pharmaceuticals in the environment.
    Ankley GT; Brooks BW; Huggett DB; Sumpter JP
    Environ Sci Technol; 2007 Dec; 41(24):8211-7. PubMed ID: 18200843
    [No Abstract]   [Full Text] [Related]  

  • 3. In response: industry perspective.
    Brown AR
    Environ Toxicol Chem; 2014 Sep; 33(9):1915-8. PubMed ID: 25138027
    [No Abstract]   [Full Text] [Related]  

  • 4. The challenge: do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question?
    Sumpter JP
    Environ Toxicol Chem; 2014 Sep; 33(9):1915. PubMed ID: 25138028
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals in the environment: scientific evidence of risks and its regulation.
    Küster A; Adler N
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving environmental risk assessment of human pharmaceuticals.
    Ågerstrand M; Berg C; Björlenius B; Breitholtz M; Brunström B; Fick J; Gunnarsson L; Larsson DG; Sumpter JP; Tysklind M; Rudén C
    Environ Sci Technol; 2015 May; 49(9):5336-45. PubMed ID: 25844810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pharmaceutical products in the environment - the "problem" in perspective.
    Taylor D; Senac T
    Chemosphere; 2014 Nov; 115():95-9. PubMed ID: 24525259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greener pharmaceuticals.
    Clark JH; Breeden SW; Summerton L
    Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
    [No Abstract]   [Full Text] [Related]  

  • 9. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
    Daughton CG
    Environ Health Perspect; 2003 May; 111(5):757-74. PubMed ID: 12727606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the special issue on environmental risk assessment of pharmaceuticals.
    Knacker T; Metcalfe C
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():511-3. PubMed ID: 20821716
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of chlorination on the persistence of pharmaceuticals in the environment.
    Glassmeyer ST; Shoemaker JA
    Bull Environ Contam Toxicol; 2005 Jan; 74(1):24-31. PubMed ID: 15768494
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge.
    Cardoso O; Porcher JM; Sanchez W
    Chemosphere; 2014 Nov; 115():20-30. PubMed ID: 24602347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sweden a world leader when it comes to drugs and environment].
    Eckerman I
    Lakartidningen; 2010 Oct 20-26; 107(42):2586. PubMed ID: 21140536
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.
    Cooper ER; Siewicki TC; Phillips K
    Sci Total Environ; 2008 Jul; 398(1-3):26-33. PubMed ID: 18440598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international conference on "Pharmaceutical products in the environment: is there a problem?" in the framework of the EU PHARMAS Project.
    Roig B; Thomas O
    Chemosphere; 2014 Nov; 115():1-3. PubMed ID: 24594485
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and personal care products: research needs for the next decade.
    Brooks BW; Huggett DB; Boxall AB
    Environ Toxicol Chem; 2009 Dec; 28(12):2469-72. PubMed ID: 19908931
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug pollution: industry responds.
    Snape J; White W
    Nature; 2015 Nov; 527(7577):165. PubMed ID: 26560288
    [No Abstract]   [Full Text] [Related]  

  • 20. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.